3D graphic showing regulatory T cells
3D graphic showing regulatory T cells
Logo

Clinical-grade enrichment of Tregs (regulatory T cells)

Take advantage of flexible Treg cell enrichment strategies in a closed system. Our automated manufacturing processes using the CliniMACS Prodigy® Platform and CliniMACS® Plus System provide a streamlined and efficient solution to your needs.

Regulatory T cells for immunotherapy

Regulatory T (Treg) cells are a specialized subpopulation of T cells that act to suppress immune responses, thereby maintaining homeostasis and self-tolerance. Their unique function has made them an interesting target cell population for immunotherapy in a number of different indications, including prevention and treatment of graft-versus-host disease (GvHD) after haploid stem cell transplantation (HSCT)1-4, suppression of solid organ rejection after transplantation5-9, and treatment of autoimmune diseases like type 1 diabetes10,11.

To address the variety of Treg cell applications, Miltenyi Biotec provides a broad range of tools for clinical use. By combining the CliniMACS Cell Manufacturing Platform with MACS GMP Products and our GMP-compliant cell sorter MACSQuant® Tyto®, you can now significantly enhance your clinical-grade Treg cell manufacturing possibilities.

Webinar

Improve your clinical-grade Treg manufacturing

Tune into this webinar as we provide you with comprehensive solutions for manufacturing clinical-grade Treg cells. Learn about how you can utilize our CliniMACS Platform and MACS GMP Products for a range of applications.

The three steps to your final clinical-grade Treg cell product

The clinical-grade Treg cell manufacturing process consists of three steps, in which regulatory T cell isolation counts as the most challenging. To meet the need of GMP-compliance, automation, scalability, and customizable cell manufacturing, we provide two approaches for isolation of regulatory T cells. Furthermore we offer unique and comprehensive solutions for Treg cell activation, cultivation, and analysis.

1. Clinical-grade Treg separation

Isolation of polyclonal Treg cells using the CliniMACS Plus.

Approach A: Cell separation using the CliniMACS Plus

Isolation of polyclonal regulatory T cells

Cell separation on the CliniMACS Plus Instrument is an easy and GMP-compliant method to magnetically isolate your CD25high Treg cells, with or without prior depletion of CD8 or CD19 cells with a high purity and recovery.

Advantages of this method:

  • Robust large-scale Treg cell enrichment
  • Convenient isolation procedure
  • Maintenance of Treg function and phenotype
  • Pre-depletion of CD8+ (and/or CD19+) cells
  • Efficient enrichment of cells highly expressing CD25

Infographic of regulatory T cell enrichment workflow with CD25 preenrichment, antibody labeling and cell sorting to final Treg product
Cell separation using the CliniMACS Prodigy and MACSQuant Tyto Cell Sorter.

Approach B: Cell separation using the CliniMACS Prodigy and MACSQuant Tyto Cell Sorter

With regulatory T cells being more and more used as treatment options to suppress solid organ rejection after transplantation, for autoimmune diseases, and as CAR Treg cells, the demand for ultra-pure antigen-specific Tregs has recently increased tremendously.

Miltenyi Biotec now offers solutions to meet the needs of the field. The combination of the CliniMACS Prodigy for pre-enrichment and the MACSQuant Tyto Cell Sorter for subsequent high-purity cell sorting guarantees full sterility of your medical product.

Automated cell separation and sorting

Isolation of a ultra-pure Treg cell subpopulation using the CliniMACS Prodigy LP-25 Pre-enrichment Process and the MACSQuant Tyto Cell Sorter.

Advantages of this method:

  • Robust ultra-pure isolation of Treg cell subpopulation (>98%)
  • Efficient enrichment of CD25+ cells and fluorescent labeling in a closed and automated system using CliniMACS Prodigy LP-25 Pre-Enrichment
  • GMP-compliant cell sorting using the MACSQuant Tyto Cell Sorter
  • Maintenance of Treg cell functionality and phenotype

2. Clinical-grade Treg cell expansion

In order to improve the purity and quantity of clinical-grade Treg cells, we offer GMP-compatible expansion products. Ideal cultivation and expansion of Treg cells rely on the strong synergy of:

  • TexMACS™ GMP Medium,
  • MACS GMP Cytokines and
  • MACS GMP Rapamycin

TexMACS GMP Medium

To enhance your Treg cell culturing, we offer TexMACS GMP medium which is specifically developed for T cell cultivation. TexMACS GMP medium is serum- and xeno-component free, but it is supplemented with pharmaceutical-grade human serum albumin. To support you with the consistently high standards, a QC functionality test is done on every batch.

MACS GMP Cytokines (IL-2)

Our MACS GMP Cytokines are designed according to the recommendations of on ancillary materials and manufactured and tested under a certified ISO 13485 quality system. In addition, we provide you with a lot-to-lot consistency and lot-specific certificates of analysis.

MACS GMP Rapamycin

Profit from MACS GMP Rapamycin to enhance the proportion of FoxP3+ Treg cells and to inhibit the expansion of conventional T cells during the cultivation and expansion step12. We offer 100 nM ready-to-use MACS GMP Rapamycin to improve your culturing.

3. Quality control testing by clinical flow cytometry

Researcher in clean room attire is starting an analysis on the flow cytometer MACSQuant Analyzer 16

In order to guarantee the safety and consistency of cell manufacturing, the implementation of robust in-process control and release testing (IPC/RT) is crucial.

Samples collected within the manufacturing process, e.g., on the CliniMACS Prodigy, are reliably analyzed on our standardized flow cytometry platform. Our comprehensive workflow solution comprises harmonized MACSQuant® Flow Cytometers, automated data acquisition and analysis (Express Modes) in an audit-ready software, and a broad portfolio of REAfinity® Recombinant Antibodies with superior specificity and reproducibility. Miltenyi Biotec provides comprehensive solutions with ready-to-use staining cocktails and functional assays.

Bar chart showing a Treg suppression assay in the presence or absence of Treg Suppression Inspector, human
Treg suppression assay using the Treg Suppression Inspector, human.

Treg cell suppression assay

The Treg Suppression Inspector has been developed for the in vitro functional characterization of human CD4+ CD25+ regulatory T cells.

Treg cell in vitro suppression assay

  • Optimized T cell stimulation reagent for Treg suppression assays
  • Based on anti-Biotin MACSiBead™ Particles
  • Analysis of Treg cell suppression activity by reduction of responder T cell proliferation

Infographic showing the REAfinity recombinant antibody model
REAfinity™ Recombinant Antibody model.

Flow cytometry analysis

REAfinity™ Recombinant Antibodies

REAfinity Antibodies are recombinant antibodies that provide superior lot-to-lot consistency and purity compared to mouse or rat hybridoma-derived, monoclonal antibodies. They have been recombinantly engineered to produce highly specific antibodies that require no FcR blocking step. Additionally, they all have the same IgG1 isotype, requiring less isotype controls.

Treg characterization with REAfinity Antibodies

  • Greater reproducibility: High purity and lot-to-lot consistency with less background
  • Easy handling: Eliminates tedious and costly Fc receptor blocking steps
  • One universal isotype: Convenient and cost-saving

Selected references: How CliniMACS Instruments perform in Treg cell enrichment

Icon selected references in turquoise

Get up to date with this selection of influential papers and reviews showing how CliniMACS Instruments have been used by your peers for clinical Treg cell enrichment.

Get personalized support for your manufacturing workflows of clinical-grade Treg cell

Unless otherwise specifically indicated, Miltenyi Biotec products and services are for research use only and not for therapeutic or diagnostic use. For complete regulatory notes, please click here.

You have previously chosen International as your location.
What do you want to do?